“…In support of this idea, CARDS toxin expression is dramatically limited
during mycoplasma growth in laboratory media, in contrast to its markedly up-regulated
synthesis during M. pneumoniae infection of the airway (Kannan et al , 2010). CARDS toxin also
elicits a strong immune response in convalescing humans and infected experimental animals
and is readily detectable in airway fluids (Kannan et al,
2010, Techasaensiri et al ,
2010, Kannan et al , 2011,
Muir et al , 2011, Peters et al, 2011, Kannan et al , 2012). Furthermore, purified recombinant CARDS
toxin elicits multiple inflammatory and temporally changing histopathological patterns in
rodents and primates in a manner similar to those observed during M.
pneumoniae infection (Hardy et al,
2009).…”